COVID-19 pandemic have plenty of homegrown options, but investing in small domestic firms carries elevated risks as well as rewards.BetterLife Pharmaceuticals Inc.
is one such company. The Vancouver firm is in final testing on a treatment for cases in which a vaccine doesn’t work or patients refuse to be inoculated.“We have a Made-in-Canada solution,” says founder and CEO Dr.
Ahmad Doroudian. His company has worked with the National Research Council and Toronto immunologist Dr. Eleanor Fish. How COVID-19 is luring Canadians into the stock market The company has developed an inhalable method to treat COVID-19 patients by helping the immune system to defeat the virus.“We think we can make an impact.